Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sitagliptin Phosphate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117467733B reveals immobilized transaminase process for Sitagliptin. Achieve high optical purity and cost reduction in API manufacturing with scalable biocatalysis.
Patent CN109824546B details a novel method for controlling condensation impurities in Sitagliptin intermediates, ensuring high purity and regulatory compliance for global supply chains.
Novel L-aspartic acid route for Sitagliptin phosphate synthesis. Cost-effective, high-purity manufacturing solution for global pharmaceutical supply chains.
Novel patent CN120040456A details green synthesis of sitagliptin phosphate offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN113149991A details a safer sitagliptin synthesis avoiding DMF and chromatography. Discover cost-effective manufacturing and high-purity supply solutions.
Patent CN117843643A reveals a high-purity sitagliptin phosphate method. Reduced solvent use and simplified steps offer significant supply chain and cost advantages.
Patent CN104987338A reveals a low-cost method for Sitagliptin phosphate key intermediate. Achieve high purity and supply chain stability with optimized Grignard processes.